000			02398 a2200697 4500
005			20250513050129.0
264		0	_c19950330
008			199503s 0 0 eng d
022			_a0887-6924
040			_aNLM _beng _cNLM
100	1		_aJurcic, J G
245	0	0	_aSequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195. _h[electronic resource]
260			_bLeukemia _cFeb 1995
300			_a244-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, Differentiation, Myelomonocytic _ximmunology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDaunorubicin _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIdarubicin _xadministration & dosage
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aLeukemia, Promyelocytic, Acute _xmortality
650	0	4	_aLife Tables
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Proteins
650	0	4	_aNeoplasm, Residual
650	0	4	_aNeutropenia _xetiology
650	0	4	_aNuclear Proteins
650	0	4	_aOncogene Proteins, Fusion _xanalysis
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPromyelocytic Leukemia Protein
650	0	4	_aReceptors, Retinoic Acid _xanalysis
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aSialic Acid Binding Ig-like Lectin 3
650	0	4	_aSurvival Analysis
650	0	4	_aTranscription Factors _xanalysis
650	0	4	_aTreatment Outcome
650	0	4	_aTretinoin _xpharmacology
650	0	4	_aTumor Suppressor Proteins
700	1		_aCaron, P C
700	1		_aMiller, W H
700	1		_aYao, T J
700	1		_aMaslak, P
700	1		_aFinn, R D
700	1		_aLarson, S M
700	1		_aWarrell, R P
700	1		_aScheinberg, D A
773	0		_tLeukemia _gvol. 9 _gno. 2 _gp. 244-8
999			_c7869095 _d7869095